310 related articles for article (PubMed ID: 37122389)
1. Alport Syndrome: Clinical Spectrum and Therapeutic Advances.
Gregorio V; Caparali EB; Shojaei A; Ricardo S; Barua M
Kidney Med; 2023 May; 5(5):100631. PubMed ID: 37122389
[TBL] [Abstract][Full Text] [Related]
2. Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome.
Akihisa T; Sato M; Wakayama Y; Taneda S; Horita S; Hirose O; Makabe S; Kataoka H; Mori T; Sohara E; Uchida S; Nitta K; Mochizuki T
Kidney Med; 2019; 1(6):391-396. PubMed ID: 32734219
[TBL] [Abstract][Full Text] [Related]
3. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
4. Genotype-Phenotype Correlations for Pathogenic
Savige J; Huang M; Croos Dabrera MS; Shukla K; Gibson J
Front Med (Lausanne); 2022; 9():865034. PubMed ID: 35602506
[TBL] [Abstract][Full Text] [Related]
5. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
[TBL] [Abstract][Full Text] [Related]
6. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
7. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.
Heidet L; Cai Y; Guicharnaud L; Antignac C; Gubler MC
Am J Pathol; 2000 Jun; 156(6):1901-10. PubMed ID: 10854213
[TBL] [Abstract][Full Text] [Related]
8. Novel Therapies for Alport Syndrome.
Chavez E; Rodriguez J; Drexler Y; Fornoni A
Front Med (Lausanne); 2022; 9():848389. PubMed ID: 35547199
[TBL] [Abstract][Full Text] [Related]
9. Searching for a treatment for Alport syndrome using mouse models.
Katayama K; Nomura S; Tryggvason K; Ito M
World J Nephrol; 2014 Nov; 3(4):230-6. PubMed ID: 25374816
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).
Jefferson JA; Lemmink HH; Hughes AE; Hill CM; Smeets HJ; Doherty CC; Maxwell AP
Nephrol Dial Transplant; 1997 Aug; 12(8):1595-9. PubMed ID: 9269635
[TBL] [Abstract][Full Text] [Related]
11. Familial hematuria: A review.
Plevová P; Gut J; Janda J
Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
[TBL] [Abstract][Full Text] [Related]
12. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.
Liang L; Wu H; Cai Z; Zhao J
BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645
[TBL] [Abstract][Full Text] [Related]
13. The renal lesions of Alport syndrome.
Heidet L; Gubler MC
J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
[TBL] [Abstract][Full Text] [Related]
14. Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome.
Gunwar S; Ballester F; Noelken ME; Sado Y; Ninomiya Y; Hudson BG
J Biol Chem; 1998 Apr; 273(15):8767-75. PubMed ID: 9535854
[TBL] [Abstract][Full Text] [Related]
15. Identification of 27 Novel Variants in Genes
Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
[TBL] [Abstract][Full Text] [Related]
16. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.
Kalluri R; Torre A; Shield CF; Zamborsky ED; Werner MC; Suchin E; Wolf G; Helmchen UM; van den Heuvel LP; Grossman R; Aradhye S; Neilson EG
Transplantation; 2000 Feb; 69(4):679-83. PubMed ID: 10708133
[TBL] [Abstract][Full Text] [Related]
17. [Alport syndrome or progressive hereditary nephritis with hearing loss].
Gubler MC; Heidet L; Antignac C
Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
[TBL] [Abstract][Full Text] [Related]
18. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of
Liang L; Wu H; Cai Z; Zhao J
Front Genet; 2023; 14():1059322. PubMed ID: 36923787
[No Abstract] [Full Text] [Related]
20. A novel variant in the
Sienes Bailo P; Bancalero Flores JL; Lahoz Alonso R; Santamaría González M; Gutiérrez Dalmau A; Álvarez de Andrés S; Izquierdo Álvarez S
Adv Lab Med; 2021 Aug; 2(3):451-462. PubMed ID: 37362409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
